|
|
||||||||
Relapse of Plasmodium vivax malaria following standard primaquine dosing has been reported from many areas, and more recently from sub-Saharan Africa. In this report we describe eight episodes (in five patients) of treatment failure in non-immune Israeli travelers returning from Ethiopia. Retrospective calculation of the primaquine dose per kilogram of body weight for 23 treatment courses showed a lower total dose per kilogram in heavier patients. The mean calculated dose (95% CI) in the eight failed treatments was 2.5 +/- 0.3 mg/kg compared with 4.4 +/- 0.5 mg/kg in the 15 successful treatment courses. Weight-adjusted dosing regimens may prevent inadvertent subtherapeutic drug failure, and thus apparent primaquine failure. In these cases, no relapses were observed in those who received > 3.5 mg/kg. Consideration should be given to adjusting the dose of primaquine according to body weight. For those infected by strains from Ethiopia a dose > 3.5 mg/kg is preferable.
This article has been cited by other articles:
![]() |
J. K. Baird Resistance to Therapies for Infection by Plasmodium vivax Clin. Microbiol. Rev., July 1, 2009; 22(3): 508 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Rodriguez, A. F. Betanzos-Reyes, J. E. Hernandez-Avila, J. F. Mendez-Galvan, R. Danis-Lozano, and A. Altamirano-Jimenez The Participation of Secondary Clinical Episodes in the Epidemiology of Vivax Malaria during Pre- and Post-Implementation of Focal Control in the State of Oaxaca, Mexico Am J Trop Med Hyg, June 1, 2009; 80(6): 889 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. BAIRD A RARE GLIMPSE AT THE EFFICACY OF PRIMAQUINE Am J Trop Med Hyg, February 1, 2007; 76(2): 201 - 202. [Full Text] [PDF] |
||||
![]() |
J. L. GOLLER, D. JOLLEY, P. RINGWALD, and B.-A. BIGGS REGIONAL DIFFERENCES IN THE RESPONSE OF PLASMODIUM VIVAX MALARIA TO PRIMAQUINE AS ANTI-RELAPSE THERAPY Am J Trop Med Hyg, February 1, 2007; 76(2): 203 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. ALVAREZ, J.-G. PINEROS, A. TOBON, A. RIOS, A. MAESTRE, S. BLAIR, and J. CARMONA-FONSECA Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia. Am J Trop Med Hyg, October 1, 2006; 75(4): 605 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. HILL, J. K. BAIRD, M. E. PARISE, L. S. LEWIS, E. T. RYAN, and A. J. MAGILL PRIMAQUINE: REPORT FROM CDC EXPERT MEETING ON MALARIA CHEMOPROPHYLAXIS I. Am J Trop Med Hyg, September 1, 2006; 75(3): 402 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. BOTTIEAU, J. CLERINX, E. VAN DEN ENDEN, M. VAN ESBROECK, R. COLEBUNDERS, A. VAN GOMPEL, and J. VAN DEN ENDE Imported non-Plasmodium falciparum malaria: a five-year prospective study in a European referral center. Am J Trop Med Hyg, July 1, 2006; 75(1): 133 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Spudick, L. S. Garcia, D. M. Graham, and D. A. Haake Diagnostic and Therapeutic Pitfalls Associated with Primaquine-Tolerant Plasmodium vivax J. Clin. Microbiol., February 1, 2005; 43(2): 978 - 981. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |